Marco Iafolla

Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab

Scott V. Bratman, S.Y. Cindy Yang, Marco Iafolla et al. · Nature Cancer · 2020 · 480 citations

Medicine, Oncology, Pharmacology +16

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity

S.Y. Cindy Yang, Scott Lien, Ben X. Wang et al. · Nature Communications · 2021 · 128 citations · Full text

Life Sciences, Immunology, Oncology +17

First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium

Shaan Dudani, Jeffrey Graham, J. Connor Wells et al. · European Urology · 2019 · 90 citations · Full text

Medicine, Oncology, Pharmacology +13

The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years

Anthea Peters, Michael S. Akinwumi, Carlos Cervera et al. · Transplantation · 2018 · 84 citations

Medicine, Immunology, Infectious Diseases +11

Abstract CT301: A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors

Juanita Lopez, D. Ross Camidge, Marco Iafolla et al. · Cancer Research · 2020 · 59 citations

Medicine, Oncology, Pharmacology +17